Moderna
Ad
related to: vertex pharmaceuticalsLearn About Our Efforts to Improve the Lives of Patients, Employees and Our Communities. We Bring Together the Brightest Minds, Invest in Science and Take Smart Risks.
- Contact Us
Find all the ways to reach us
for the information you need.
- Our Company
Learn about our mission and
the values that drive us.
- News
Stay current on all things Vertex
and discover the latest news.
- Our Unique Approach
See What Makes Us Unique
And How We Put Science First.
- Contact Us
Search results
Vertex Pharmaceuticals | Home. At Vertex, we invest in scientific innovation to create transformative medicines for people with serious diseases. Read More. News. Jennifer Schneider elected to Vertex Board of Directors. Learn more. Vertex reports first quarter 2024 financial results. Learn More.
- Our Approved Medicines
Our Approved Medicines - Vertex Pharmaceuticals | Home
- Our Company
In 2023, we ranked #12 in the Mega Employer category. Vertex...
- Our Science
Our Science - Vertex Pharmaceuticals | Home
- Patients
Patients - Vertex Pharmaceuticals | Home
- Responsibility
At Vertex, giving back includes providing opportunities to...
- Our Approved Medicines
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Dec 8, 2023 · BOSTON & ZUG, Switzerland -- (BUSINESS WIRE)--Dec. 8, 2023-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) announced today that the U.S. Food and Drug Administration (FDA) has approved CASGEVY™ (exagamglogene autotemcel [exa-cel]), a CRISPR/Cas9 genome-edited cell therapy, for the treatment of ...
Jan 30, 2024 · BOSTON -- (BUSINESS WIRE)--Jan. 30, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced positive results from its Phase 3 program for the selective NaV1.8 inhibitor, VX-548, in the treatment of moderate-to-severe acute pain.
Oct 3, 2023 · BOSTON -- (BUSINESS WIRE)--Oct. 3, 2023-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today presented longer-term data on patients dosed in Parts A and B of its Phase 1/2 clinical trial of VX-880, an investigational stem cell-derived, fully differentiated islet cell therapy in people with type 1 diabetes (T1D) with impaired hypoglycemic a...
Dec 8, 2023 · BOSTON & ZUG, Switzerland, December 08, 2023 -- ( BUSINESS WIRE )-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) announced today that the U.S. Food...
People also ask
Who is Vertex Pharmaceuticals?
Is Vertex Pharmaceuticals a good place to work?
Where is vertex based?
What does vertex do?
Ad
related to: vertex pharmaceuticalsLearn About Our Efforts to Improve the Lives of Patients, Employees and Our Communities. Stay Current on All Things Vertex and Hear From Leaders on Topics That Matter Most to Us.
